{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:53:40Z","timestamp":1791118420360,"version":"4.1.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1309\/lrkx8ce7gvpcr1ft","type":"journal-article","created":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T20:44:55Z","timestamp":1179434695000},"page":"869-880","source":"Crossref","is-referenced-by-count":128,"title":["Hepatosplenic and Other \u03b3\u0394 T-Cell Lymphomas"],"prefix":"10.1093","volume":"127","author":[{"given":"Francisco","family":"Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,6,1]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Kadin ME, Kamoun M, Lamberg J. Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis. <i>N Engl J Med.<\/i> 1981; <b>304<\/b>:648-653.","DOI":"10.1056\/NEJM198103123041106"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. <i>Blood.<\/i> 1990; <b>75<\/b>:2213-2219.","DOI":"10.1182\/blood.V75.11.2213.bloodjournal75112213"},{"key":"E00003","unstructured":"Gaulard P, Bourquelot P, Kanavaros P, et al. Expression of the alpha\/beta and gamma\/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas; identification of a subset of gamma\/delta T-cell lymphomas. <i>Am J Pathol.<\/i> 1990; <b>137<\/b>:617-628."},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Bucy RP, Chen CL, Cooper MD. Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans. <i>J Immunol.<\/i> 1989; <b>142<\/b>:3045-3049.","DOI":"10.4049\/jimmunol.142.9.3045"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Bordessoule D, Gaulard P, Mason DY. Preferential localisation of human lymphocytes bearing gamma delta T cell receptors to the red pulp of the spleen. <i>J Clin Pathol.<\/i> 1990; <b>43<\/b>:461-464.","DOI":"10.1136\/jcp.43.6.461"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Garcia-Sanchez F, Menarguez J, Cristobal E, et al. Hepatosplenic gamma-delta T-cell malignant lymphoma: report of the first case in childhood, including molecular minimal residual disease follow-up. <i>Br J Haematol.<\/i> 1995; <b>90<\/b>:943-946.","DOI":"10.1111\/j.1365-2141.1995.tb05221.x"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Wong KF, Chan JK, Matutes E, et al. Hepatosplenic gamma delta T-cell lymphoma: a distinctive aggressive lymphoma type. <i>Am J Surg Pathol.<\/i> 1995; <b>19<\/b>:718-726.","DOI":"10.1097\/00000478-199506000-00013"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic \u03b3\u03b4 T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. <i>Blood.<\/i> 2003; <b>102<\/b>:4261-4269.","DOI":"10.1182\/blood-2003-05-1675"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Francois A, Lesesve JF, Stamatoullas A, et al. Hepatosplenic gamma\/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q. <i>Am J Surg Pathol.<\/i> 1997; <b>21<\/b>:781-790.","DOI":"10.1097\/00000478-199707000-00006"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Wu H, Wasik MA, Przybylski G, et al. Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. <i>Am J Clin Pathol.<\/i> 2000; <b>113<\/b>:487-496.","DOI":"10.1309\/YTTC-F55W-K9CP-EPX5"},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Khan WA, Yu L, Eisenbrey AB, et al. Hepatosplenic gamma\/delta T-cell lymphoma in immunocompromised patients: report of two cases and review of literature. <i>Am J Clin Pathol.<\/i> 2001; <b>116<\/b>:41-50.","DOI":"10.1309\/TC9U-FAV7-0QBW-6DFC"},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Steurer M, Stauder R, Grunewald K, et al. Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation. <i>Hum Pathol.<\/i> 2002; <b>33<\/b>:253-258.","DOI":"10.1053\/hupa.2002.31301"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Vega F, Medeiros LJ, Bueso-Ramos C, et al. Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow; a sinusoidal neoplasm with blastic cytologic features. <i>Am J Clin Pathol.<\/i> 2001; <b>116<\/b>:410-419.","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H"},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Aldinucci D, Poletto D, Zagonel V, et al. In vitro and in vivo effects of 2'-deoxycoformycin (pentostatin) on tumour cells from human gammadelta+ T-cell malignancies. <i>Br J Haematol.<\/i> 2000; <b>110<\/b>:188-196.","DOI":"10.1046\/j.1365-2141.2000.02129.x"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Nosari A, Oreste PL, Biondi A, et al. Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome. <i>Am J Hematol.<\/i> 1999; <b>60<\/b>:61-65.","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<61::AID-AJH10>3.0.CO;2-L"},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Jones D, Vega F, Sarris AH, et al. CD4-CD8-\"double-negative\" cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course. <i>Am J Surg Pathol.<\/i> 2002; <b>26<\/b>:225-231.","DOI":"10.1097\/00000478-200202000-00009"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Lai R, Larratt LM, Etches W, et al. Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia. <i>Am J Surg Pathol.<\/i> 2000; <b>24<\/b>:459-463.","DOI":"10.1097\/00000478-200003000-00016"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Macon WR, Levy NB, Kurtin PJ, et al. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. <i>Am J Surg Pathol.<\/i> 2001; <b>25<\/b>:285-296.","DOI":"10.1097\/00000478-200103000-00002"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Suarez F, Wlodarska I, Rigal-Huguet F, et al. Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma. <i>Am J Surg Pathol.<\/i> 2000; <b>24<\/b>:1027-1032.","DOI":"10.1097\/00000478-200007000-00016"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Cooke CB, Krenacs L, Stetler-Stevenson M, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. <i>Blood.<\/i> 1996; <b>88<\/b>:4265-4274.","DOI":"10.1182\/blood.V88.11.4265.4265"},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Boulland ML, Kanavaros P, Wechsler J, et al. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. <i>J Pathol.<\/i> 1997; <b>183<\/b>:432-439.","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<432::AID-PATH942>3.0.CO;2-4"},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Krenacs L, Smyth MJ, Bagdi E, et al. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. <i>Blood.<\/i> 2003; <b>101<\/b>:3590-3593.","DOI":"10.1182\/blood-2002-09-2908"},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Ohshima K, Haraoka S, Harada N, et al. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. <i>Histopathology.<\/i> 2000; <b>36<\/b>:127-135.","DOI":"10.1046\/j.1365-2559.2000.00804.x"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Alonsozana EL, Stamberg J, Kumar D, et al. Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma. <i>Leukemia.<\/i> 1997; <b>11<\/b>:1367-1372.","DOI":"10.1038\/sj.leu.2400742"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Wlodarska I, Martin-Garcia N, Achten R, et al. Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. <i>Genes Chromosomes Cancer.<\/i> 2002; <b>33<\/b>:243-251.","DOI":"10.1002\/gcc.10021"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Przybylski GK, Wu H, Macon WR, et al. Hepatosplenic and subcutaneous panniculitis-like gamma\/delta T cell lymphomas are derived from different Vdelta subsets of gamma\/delta T lymphocytes. <i>J Mol Diagn.<\/i> 2000; <b>2<\/b>:11-19.","DOI":"10.1016\/S1525-1578(10)60610-1"},{"key":"E00027","unstructured":"Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. <i>Blood.<\/i> 1998; <b>91<\/b>:1723-1731."},{"key":"E00028","doi-asserted-by":"crossref","unstructured":"Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. <i>Blood.<\/i> 2005; <b>105<\/b>:3768-3785.","DOI":"10.1182\/blood-2004-09-3502"},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"Gonzalez CL, Medeiros LJ, Braziel RM, et al. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. <i>Am J Surg Pathol.<\/i> 1991; <b>15<\/b>:17-27.","DOI":"10.1097\/00000478-199101000-00002"},{"key":"E00030","doi-asserted-by":"crossref","unstructured":"Sen F, Rassidakis GZ, Jones D, et al. Apoptosis and proliferation in subcutaneous panniculitis-like T-cell lymphoma. <i>Mod Pathol.<\/i> 2002; <b>15<\/b>:625-631.","DOI":"10.1038\/modpathol.3880577"},{"key":"E00031","doi-asserted-by":"crossref","unstructured":"Felgar RE, Salhany KE, Macon WR, et al. The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features. <i>Hum Pathol.<\/i> 1999; <b>30<\/b>:228-236.","DOI":"10.1016\/S0046-8177(99)90281-2"},{"key":"E00032","doi-asserted-by":"crossref","unstructured":"Vermeer MH, Geelen FA, Kummer JA, et al. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. <i>Am J Pathol.<\/i> 1999; <b>154<\/b>:1203-1210.","DOI":"10.1016\/S0002-9440(10)65372-2"},{"key":"E00033","doi-asserted-by":"crossref","unstructured":"Osuji N, Matutes E, Tjonnfjord G, et al. T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature. <i>Cancer.<\/i> 2006; <b>107<\/b>:570-578.","DOI":"10.1002\/cncr.22032"},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"Morice WG, Kurtin PJ, Tefferi A, et al. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. <i>Blood.<\/i> 2002; <b>99<\/b>:268-274.","DOI":"10.1182\/blood.V99.1.268"},{"key":"E00035","doi-asserted-by":"crossref","unstructured":"Loughran TP Jr. Clonal diseases of large granular lymphocytes. <i>Blood.<\/i> 1993; <b>82<\/b>:1-14.","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211"},{"key":"E00036","doi-asserted-by":"crossref","unstructured":"Vie H, Chevalier S, Garand R, et al. Clonal expansion of lymphocytes bearing the gamma delta T-cell receptor in a patient with large granular lymphocyte disorder. <i>Blood.<\/i> 1989; <b>74<\/b>:285-290.","DOI":"10.1182\/blood.V74.1.285.285"},{"key":"E00037","doi-asserted-by":"crossref","unstructured":"Saito T, Togitani K, Murakami J, et al. Granular lymphocytic leukemia derived from gamma delta T-cell expressing cytotoxic molecules. <i>Leuk Res.<\/i> 2001; <b>25<\/b>:259-261.","DOI":"10.1016\/S0145-2126(00)00115-6"},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. <i>Blood.<\/i> 1997; <b>89<\/b>:4501-4513.","DOI":"10.1182\/blood.V89.12.4501"},{"key":"E00039","doi-asserted-by":"crossref","unstructured":"Morice WG, Macon WR, Dogan A, et al. NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis. <i>Leukemia.<\/i> 2006; <b>20<\/b>:883-886.","DOI":"10.1038\/sj.leu.2404168"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/127\/6\/869\/4988235\/ajcpath127-0869.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T18:15:57Z","timestamp":1683828957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/LRKX8CE7GVPCR1FT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2007,6,1]]},"published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1309\/LRKX8CE7GVPCR1FT"],"URL":"https:\/\/doi.org\/10.1309\/lrkx8ce7gvpcr1ft","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}